Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Beth Psaila has been awarded a Wellcome Trust Postdoctoral Fellowship.

Beth_Psaila

Beth will work with Adam Mead and Irene Roberts on the role of megakaryocytes in myelofibrosis (MF), using single cell profiling to study the molecular mechanisms underlying abnormal megakaryopoiesis in MF and the pathways by which megakaryocytes contribute to bone marrow fibrosis.
 
She will spend the first 2 years of her Fellowship working in David Bodine's lab at the National Human Genome Research Institute at the NIH, USA.  Beth will also collaborate with Shuomo Bhattacharya (Wellcome Trust Centre for Human Genetics, Oxford) to use high-throughput screening of molecules that regulate collagen fibrosis.

Similar stories

Giulia Orlando becomes a John Goldman Fellow

Many congratulations to Dr Giulia Orlando, who has become a 2021 Leukaemia UK John Goldman Fellow.

New atlas revealed of bone marrow haematopoiesis during development

A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.

Changes in blood cell production over the human lifetime may hold clues to patterns of disease

A new paper published in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.

New Associate Professor appointments announced

Congratulations to Dr Bethan Psaila, Dr Benjamin Fairfax, Dr Hashem Koohy, Dr Andrew Blackford and Dr Oliver Bannard who have all been awarded the title of Associate Professor in recognition of their research achievements, contribution to teaching and contributions to the Medical Sciences Division.

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.